Search

Bruker Corp

Fechado

SetorSaúde

58.92 -2.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

56.39

Máximo

68.65

Indicadores-chave

By Trading Economics

Rendimento

-67M

-51M

Vendas

15M

839M

EPS

0.49

Rendimento de Dividendos

0.35

Margem de lucro

-6.07

Funcionários

11,085

EBITDA

-71M

17M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+17.7% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

0.35%

1.96%

Próxima data de dividendos

1 de jan. de 2027

Próxima data de ex-dividendo

7 de dez. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.3B

8.5B

Abertura anterior

61.19

Fecho anterior

58.92

Bruker Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de nov. de 2026, 21:02 UTC

News

Bruker Corporation reported Q3 revenue of $874 million, exceeding estimates, and a non-GAAP EPS of $0.56, above the expected $0.42.

3 de nov. de 2026, 22:51 UTC

Bruker Corporation is declining in after-market trading, reaching its lowest point of the day and remaining below its 20-day moving average.

2 de nov. de 2026, 21:04 UTC

Correlated Moves

Bruker Corporation shares are declining, continuing a downward trend since Friday's close, alongside a drop in Revvity, Inc.

31 de out. de 2026, 00:01 UTC

Bruker Corporation's shares were roughly flat during after-market hours on Friday, settling near the lower end of their one-month range.

30 de out. de 2026, 21:31 UTC

Bruker Corporation's shares have traded lower in after-market hours, retreating from an early high and near the low end of its one-month range.

29 de out. de 2026, 23:31 UTC

Bruker Corporation's shares are declining in after-market hours amid a broader market downturn, despite earlier recovery attempts during the session.

28 de out. de 2026, 19:56 UTC

Bruker Corporation shares are higher during Wednesday's session, maintaining a solid position above their 20-day moving average despite a slight retracement from an early spike.

27 de out. de 2026, 19:52 UTC

Bruker Corporation shares are trading higher, maintaining a position above their 20-day moving average, despite a slight pullback earlier in the session.

26 de out. de 2026, 19:36 UTC

Bruker Corp shares are trading modestly higher, although they remain below their 20-day moving average and near the lower end of their one-month range.

23 de out. de 2026, 23:06 UTC

Bruker Corp shares are advancing in after-market hours, tracking the broader market's upward movement despite mixed economic signals and rising oil prices.

22 de out. de 2026, 20:07 UTC

Correlated Moves

Bruker Corp shares are declining amid broader market weakness, reversing earlier gains despite positive price target upgrades from analysts.

21 de out. de 2026, 20:01 UTC

Bruker Corp shares are sharply higher, continuing a trend of gains since Tuesday's close amid a broader market shift in dynamics.

20 de out. de 2026, 21:31 UTC

News

Bruker Corp will release its Q3 2026 financial results on November 4, 2026, and hold a conference call at 8:30 a.m. EDT.

16 de out. de 2026, 20:07 UTC

Bruker Corp shares are declining, facing consistent selling pressure and closing significantly below the 20-day moving average amid a negative cumulative return for the day.

15 de out. de 2026, 20:02 UTC

Correlated Moves

Bruker Corp shares are advancing, reflecting a broader trend in the life sciences sector, amid gains in Thermo Fisher Scientific following positive analyst ratings.

14 de out. de 2026, 20:07 UTC

News

JPMorgan downgraded Bruker Corp from Overweight to Neutral, lowering its price target from $60 to $42, citing a reassessment of growth prospects.

13 de out. de 2026, 20:07 UTC

Bruker Corp shares fell, remaining near the lower end of their one-month range and below the 20-day moving average.

12 de out. de 2026, 20:01 UTC

Correlated Moves

Bruker Corp shares are declining amid a significant drop in 10X Genomics Inc, which has reversed a trend of higher daily closes.

8 de out. de 2026, 20:07 UTC

Bruker Corp shares fell sharply, continuing a three-session decline, after hitting a low shortly after the market opened and closing below the 20-day moving average.

7 de out. de 2026, 20:07 UTC

News
Correlated Moves

Bruker Corp's stock declined after Barclays raised its price target to $70.00, as market participants viewed the upgrade as insufficiently bullish.

6 de out. de 2026, 20:00 UTC

Correlated Moves

Bruker Corp shares fell sharply as the overall market declined, influenced by the performance of correlated asset 10X Genomics Inc, which is also lower.

2 de out. de 2026, 20:07 UTC

Bruker Corp is advancing, maintaining a strong position after closing higher since Thursday, despite pulling back slightly earlier in the session.

1 de out. de 2026, 19:51 UTC

Bruker Corp shares fell sharply, marking a departure from recent higher daily closes amid a broader market shift in momentum.

30 de set. de 2026, 21:01 UTC

Bruker Corp has declined in after-market trading, reversing earlier regular-session gains, though it remains above its 20-day moving average.

29 de set. de 2026, 23:11 UTC

Bruker Corp is showing an upward movement in after-market trading, with notable gains since Tuesday's close and remaining significantly above its 20-day moving average.

28 de set. de 2026, 20:01 UTC

News

Bruker Corporation's stock fell after an earlier gain, despite unveiling new workflows aimed at advancing drug discovery and disease research at a major conference.

25 de set. de 2026, 20:07 UTC

Bruker Corp shares are modestly higher, supported by a broadly advancing market, and are trading near the upper end of their one-month range.

24 de set. de 2026, 23:15 UTC

Bruker Corp shares are trading modestly higher in after-market hours, supported by positive economic data on jobless claims and new home sales.

23 de set. de 2026, 20:07 UTC

Bruker Corp's shares fell sharply after an early high, despite remaining above the 20-day moving average and near the upper end of its one-month range.

22 de set. de 2026, 23:01 UTC

Bruker Corp is advancing in after-market trading, reaching a peak return and remaining well above its 20-day moving average.

Comparação entre Pares

Variação de preço

Bruker Corp Previsão

Preço-alvo

By TipRanks

17.7% parte superior

Previsão para 12 meses

Média 66.5 USD  17.7%

Máximo 80 USD

Mínimo 55 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Bruker Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

3

Comprar

2

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat